AbbVie Reports Third-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
AbbVie (ABBV) Tops Q3 EPS by 10c, Offers Guidance
October 29, 2021 7:42 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $3.33, $0.10 better than the analyst estimate of $3.23. Revenue for the quarter came in at $14.34 billion versus the consensus estimate of $14.35 billion.
GUIDANCE:
AbbVie sees FY2021 EPS of $12.63-$12.67, versus the consensus of... More
